REG - Life Settlement - Update on MBC Auction

Life Settlement AssetsAnnouncement

12/12/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221212:nRSL2940Ja&default-theme=true

RNS Number : 2940J  Life Settlement Assets PLC  12 December 2022

Life Settlement Assets PLC ("LSA")

LEI: 2138003OL2VBXWG1BZ27

Further update re sale of Mutual Benefits Keep Policy Trust ("MBC")

 

Following LSA's 5 December announcement in relation to the sale of MBC, LSA is
pleased to announce that Acheron Portfolio Trust, on behalf of LSA, has
entered into a high-level agreement with Mutual Benefits Keep Policy Trust to
acquire all remaining policies held by that entity. A fully settled agreement
is expected to be signed in the next two weeks, at which time further
information will be released.

 

 

12 December 2022

 

 

For further information contact

Acheron Capital Limited (Investment Manager)

Jean-Michel Paul

020 7258 5990

 

Shore Capital (Financial Adviser and Broker)

Robert Finlay

020 7408 4090

 

ISCA Administration Services Limited

Company Secretary

Tel: 01392 487056

 

Notes to Editors

Life Settlement Assets PLC is a closed-ended investment trust company which
invests in, and manages, portfolios of whole and fractional interests in life
settlement policies issued by life insurance companies operating predominantly
in the United States. The Company seeks to generate long-term returns for
investors by investing in the life settlement market, through each of the
separate Share Classes. The Company aims to manage its investment in
portfolios of life settlement products so that the realised value of the
policy maturities exceeds the aggregate cost of acquiring the policies,
ongoing premiums, management fees and other operational costs.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  STRGPGRWPUPPGRG